Tom Dreisbach

Tom Dreisbach appears in the following:

Nearly 1 In 5 Defendants In Capitol Riot Cases Served In The Military

Thursday, January 21, 2021

Amid rising concern over domestic extremism, an NPR analysis found military veterans were overrepresented in those charged in the attack on the U.S. Capitol when compared to the general population.

Comment

After Deadly Capitol Riot, Fox News Stays Silent On Stars' Incendiary Rhetoric

Wednesday, January 13, 2021

Many Fox News hosts, commentators and guests helped stoke the pro-Trump protests that became an assault on Congress. Among those influenced was Ashli Babbitt, who died while storming the Capitol.

Comment

Authorities Identify Woman Killed By Police During U.S. Capitol Rioting

Thursday, January 07, 2021

The woman killed by United States Capitol Police was identified as Ashli E. Babbitt, 35, of San Diego. She was one of four who died during Wednesday's events.

Comment

Stock Sales By Leaders At Coronavirus Testing Company Raise Legal Concerns

Wednesday, December 02, 2020

Co-Diagnostics, a company that has provided coronavirus tests to three state governments, has come under intense scrutiny for claims about its tests' accuracy and stock sales by company leaders.

Comment

Federal Trade Commission Cracks Down On Unproven COVID-19 Treatment

Thursday, November 12, 2020

The Federal Trade Commission issued warning letters to several companies that marketed an unproven drug to treat COVID-19. Sales of the nonapproved drug, thymosin alpha-1, were first reported by NPR.

Comment

Pfizer CEO Sold Millions In Stock After Coronavirus Vaccine News, Raising Questions

Wednesday, November 11, 2020

Pfizer's CEO sold $5.6 million worth of stock on Monday. The company says the stock sale was made as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.

Comment

Pfizer CEO's Stock Sale Raises Questions About Timing

Wednesday, November 11, 2020

Pfizer's CEO sold $5.6 million worth of stock on Monday. The company says the stock sale was made as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.

Comment

Congressman Calls For Federal Crackdown On Unproven Coronavirus Treatment

Wednesday, October 28, 2020

An NPR investigation revealed a network of doctors marketing a non-FDA approved drug as a purported treatment for COVID-19. Now, Rep. Raja Krishnamoorthi (D-Ill.) is calling for federal enforcement.

Comment

GOP Welcomes Steve Wynn's Millions, Despite Rape And Harassment Allegations

Wednesday, October 21, 2020

Former casino mogul Steve Wynn has been accused of rape, sexual assault and harassment. Still, politicians have continued to accept major campaign contributions from Wynn, who has denied wrongdoing.

Comment

Web Of 'Wellness' Doctors Promote Injections Of Unproven Coronavirus Treatment

Thursday, October 01, 2020

An NPR investigation has identified a web of more than 30 medical practices and compounding pharmacies in over a dozen states that have made claims about thymosin alpha-1 online and on social media.

Comment

Is It Legal To Call A Haircut A Business Expense?

Tuesday, September 29, 2020

The New York Times reported that President Trump deducted more than $70,000 in expenses related to hairstyling while he was on The Apprentice. NPR discusses whether doing so is legal.

Comment

'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns

Friday, September 04, 2020

Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.

Comment

RNC Speaker Facing Federal Charges Of Insider Trading

Tuesday, August 25, 2020

Earlier this month, Jack Brewer, a former NFL player and a supporter of President Trump's reelection, was sued by the SEC. Now, he's set to speak at the Republican National Convention.

Comment

Who Is Louis DeJoy? U.S. Postmaster General In Spotlight Ahead Of 2020 Election

Friday, August 21, 2020

Postmaster General Louis DeJoy, a longtime Republican donor, controls the U.S. Postal Service at a time when mail-in voting is central to the presidential election.

Comment

Under Trump, SEC Enforcement Of Insider Trading Dropped To Lowest Point In Decades

Friday, August 14, 2020

Kodak and Sen. Richard Burr, R-N.C., are facing high-profile insider trading investigations, but data show the Securities and Exchange Commission pursued far fewer insider trading cases last year.

Comment

On Amazon, Dubious 'Antiviral' Supplements Proliferate Amid Pandemic

Monday, July 27, 2020

Federal law generally prohibits dietary supplements from claiming to treat specific diseases or viruses. Yet NPR found more than 100 products sold on Amazon that make unsubstantiated antiviral claims.

Comment

She's A Frontline Doctor. Her Husband Has Lung Cancer. Now, A Simple Hug Is Dangerous

Sunday, June 07, 2020

When Lauren Jenkins learned a coworker had tested positive for the coronavirus, she did what once would've seemed unthinkable — separating from her two young boys and a husband with stage IV cancer.

Comment

LA Sues California Company, Alleging 'Sophisticated' COVID-19 Fraud

Wednesday, May 27, 2020

The city attorney accuses Wellness Matrix Group of "shocking deceptive conduct" over its sales of purported "at-home" coronavirus tests and virus-killing disinfectant.

Comment

Los Angeles Authorities Sue A Company For Coronavirus-Related Fraud

Wednesday, May 27, 2020

Los Angeles authorities announce a lawsuit against Wellness Matrix Group company for selling non-FDA-approved tests and making false claims about their disinfectant.

Comment

LA Reaches Legal Settlement With Company For 'False Advertising' Of COVID-19 Test

Saturday, April 25, 2020

The Los Angeles city attorney reached a settlement with RootMD over sales of "at-home Covid-19 exposure and immunity tests." The city attorney alleged RootMD violated food and drug regulations.

Comment